Calgary, Alberta —  FluroTech Ltd. (TEST), (“FluroTech” or the “Company”), is pleased to announce two recently-filed patent applications to which the Company holds exclusive, irrevocable rights for use in the cannabis industry. The patents include an international patent application filed October 31, 2018 pursuant to the Patent Cooperation Treaty (“PCT”), and a national phase entry filing of the PCT application at the United States Patent and Trademark Office (the “USPTO”) on November 2, 2018. The PCT application allows for protection of the intellectual property in 152 countries, while the application at the USPTO will accelerate substantive input from the USPTO. The patent applications protect features of FluroTech’s instrument that provide signal stability in the face of thermal and other fluctuations in the light source. These advances are utilized in the CompleTest(TM)device and roadside testing device resulting in unparalleled levels of sensitivity, signal stability and accuracy for portable instruments. Applications on other advanced designs for future generations of the device to maintain the Company’s technical lead are in progress.

“Our team has achieved a unique instrument design for unparalleled sensitivity and accuracy for a class of instruments that allows on-site cannabis testing and roadside testing without needing highly trained experts,” commented Dr. Elmar Prenner, Chief Technology Officer at FluroTech.

Additionally, efforts to patent an innovative approach to biomarking are well underway. The Company believes that biomarking will revolutionize identification of regulated commercial cannabis and allow direct product tracking from the grower to the end-user.

About FluroTech (TEST)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.